World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
56
Citations
21359
World Ranking
3665
National Ranking
150

Steven A. Krilis publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Steven A. Krilis sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 155 publications — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Steven A. Krilis D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Steven A. Krilis sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Steven A. Krilis is affiliated with the University of New South Wales in Australia and has contributed extensively to medical research, particularly in rheumatology and immunology.

Their research spans several fields of study including:

  • Medicine
  • Rheumatology
  • Hematology
  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine
  • Immunology

Main topics addressed in their work include:

  • Systemic Lupus Erythematosus Research
  • Platelet Disorders and Treatments
  • Cell Adhesion Molecules Research
  • Vasculitis and related conditions
  • Atherosclerosis and Cardiovascular Diseases
  • Calpain Protease Function and Regulation
  • Lipoproteins and Cardiovascular Health

Steven A. Krilis has published multiple articles in known venues such as:

  • Journal of Autoimmunity
  • Annals of the Rheumatic Diseases
  • Arteriosclerosis Thrombosis and Vascular Biology
  • Clinical Immunology

Notable recent papers include:

  • "2023 ACR/EULAR antiphospholipid syndrome classification criteria," 2023, Annals of the Rheumatic Diseases
  • "Free Thiol β2-GPI (β-2-Glycoprotein-I) Provides a Link Between Inflammation and Oxidative Stress in Atherosclerotic Coronary Artery Disease," 2020, Arteriosclerosis Thrombosis and Vascular Biology
  • "Βeta-2-glycoprotein I exerts antithrombotic function through its domain V in mice," 2021, Journal of Autoimmunity
  • "Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk," 2021, Journal of Autoimmunity
  • "Domain 5 of Beta 2 glycoprotein I: Friend or foe in health? Context matters," 2024, Clinical Immunology

Frequent co-authors collaborating with Steven A. Krilis include:

  • Bill Giannakopoulos
  • Miao Qi
  • Medha Barbhaiya
  • Stéphane Zuily
  • Ray Naden

Best Publications

  • International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

    S. Miyakis;M. D. Lockshin;T. Atsumi;D. W. Branch

  • Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).

    H P McNeil;R J Simpson;C N Chesterman;S A Krilis

  • The Pathogenesis of the Antiphospholipid Syndrome

    Bill Giannakopoulos;Steven A Krilis

  • Immunology and clinical importance of antiphospholipid antibodies.

    H P McNeil;C N Chesterman;S A Krilis

  • Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies

    G. Ruiz-Irastorza;M. J. Cuadrado;I. Ruiz-Arruza;Robin L Brey

  • A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection.

    J E Hunt;H P McNeil;G J Morgan;R M Crameri

  • Current concepts on the pathogenesis of the antiphospholipid syndrome.

    Bill Giannakopoulos;Freda Passam;Soheila Rahgozar;Steven A. Krilis

  • Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population

    W. Shi;S. A. Krilis;B. H. Chong;S. Gordon

  • How we diagnose the antiphospholipid syndrome

    Bill Giannakopoulos;Freda Passam;Yiannis Ioannou;Steven A. Krilis

  • Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity.

    J E Hunt;R J Simpson;S A Krilis

  • Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka

    David Andresen;Annabelle Donaldson;Lennart Choo;Adrian Knox

  • Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics.

    H. Patrick McNeil;Colin N. Chesterman;Steven A. Krilis

  • Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity.

    Yonghua Sheng;Andrej Sali;Herbert Herzog;Jelle Lahnstein

  • Anti–β2‐glycoprotein I antibodies in complex with β2‐glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib‐IX‐V

    Tong Shi;B M Giannakopoulos;X Yan;Pei Yu

  • Coronary artery bypass graft failure--an autoimmune phenomenon?

    KarenE Morton;KarenE Morton;StevenA Krilis;StevenA Krilis;DavidW Baron;DavidW Baron;ThomasP Gavaghan;ThomasP Gavaghan

  • Beta 2 glycoprotein I--function in health and disease

    Spiros Miyakis;Bill Giannakopoulos;Steven A. Krilis

  • Development of Mast Cells and Importance of Their Tryptase and Chymase Serine Proteases in Inflammation and Wound Healing

    Jeffrey Douaiher;Julien Succar;Luca Lancerotto;Michael Fagersten Gurish

  • Use of Single Point Mutations in Domain I of β2-Glycoprotein I to Determine Fine Antigenic Specificity of Antiphospholipid Autoantibodies

    G. Michael Iverson;Stephen Reddel;Edward J. Victoria;Keith A. Cockerill

  • Human β2-Glycoprotein I Binds to Endothelial Cells Through a Cluster of Lysine Residues That Are Critical for Anionic Phospholipid Binding and Offers Epitopes for Anti-β2-Glycoprotein I Antibodies

    N. Del Papa;Y. H. Sheng;E. Raschi;D. A. Kandiah

  • Essential role for mast cell tryptase in acute experimental colitis

    Matthew J. Hamilton;Mark J. Sinnamon;Gregory D. Lyng;Jonathan N. Glickman

  • RasGRP4, a New Mast Cell-restricted Ras Guanine Nucleotide-releasing Protein with Calcium- and Diacylglycerol-binding Motifs IDENTIFICATION OF DEFECTIVE VARIANTS OF THIS SIGNALING PROTEIN IN ASTHMA, MASTOCYTOSIS, AND MAST CELL LEUKEMIA PATIENTS AND DEMONSTRATION OF THE IMPORTANCE OF RasGRP4 IN MAST CELL DEVELOPMENT AND FUNCTION

    Yi Yang;Lixin Li;Guang W. Wong;Steven A. Krilis

  • Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro.

    N. Di Simone;E. Raschi;C. Testoni;R. Castellani

  • Beta 2-glycoprotein I.

    David A. Kandiah;Steven A. Krilis

Frequent Co-Authors

Richard L. Stevens
Richard L. Stevens Brigham and Women's Hospital
Colin N. Chesterman
Colin N. Chesterman University of New South Wales
Brian A. Baldo
Brian A. Baldo University of Sydney
Antony Basten
Antony Basten Garvan Institute of Medical Research
Andrej Sali
Andrej Sali University of California, San Francisco
Takao Koike
Takao Koike Hokkaido University
E. J. Corey
E. J. Corey Harvard University
Robert A. Lewis
Robert A. Lewis University of California, San Francisco
Tatsuya Atsumi
Tatsuya Atsumi Hokkaido University
Angela Tincani
Angela Tincani University of Brescia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens up diverse career pathways, especially when paired with related healthcare qualifications. Many students interested in advancing their careers choose to explore fast-track nursing programs that complement immunology expertise.

For those with a non-nursing background, enrolling in online RN programs for non nurses in Florida offers an excellent bridge into nursing careers without relocating. These programs provide a comprehensive foundation to work in clinical or research settings that intersect with immunological studies.

If speed is a priority, accelerated FNP programs allow licensed nurses to become family nurse practitioners quickly, enabling them to apply immunological concepts at an advanced clinical level.

Additionally, accelerated options such as accelerated BSN programs for non nurses can facilitate the transition into nursing with a faster timeline, perfect for those eager to start hands-on work in healthcare environments.

For entry-level positions, exploring the best easiest LPN programs to get into offers a practical starting point. These programs help build foundational clinical skills and can serve as a stepping stone toward higher-level immunology-related healthcare roles.

Best Scientists Citing Steven A. Krilis

Trending Scientists

Recently Published Articles